Dreijerink KMA - Search Results

1

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.

Conemans EB, Lodewijk L, Moelans CB, Offerhaus GJA, Pieterman CRC, Morsink FH, Dekkers OM, de Herder WW, Hermus AR, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Brosens LAA, Dreijerink KMA, Borel Rinkes IHM, Timmers HTM, Valk GD, Vriens MR. Conemans EB, et al. Among authors: dreijerink kma. Eur J Endocrinol. 2018 Sep;179(3):153-160. doi: 10.1530/EJE-18-0195. Epub 2018 Jun 14. Eur J Endocrinol. 2018. PMID: 29903750

2

Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease.

Dreijerink KM, van Beek AP, Lentjes EG, Post JG, van der Luijt RB, Canninga-van Dijk MR, Lips CJ. Dreijerink KM, et al. Eur J Endocrinol. 2005 Dec;153(6):741-6. doi: 10.1530/eje.1.02022. Eur J Endocrinol. 2005. PMID: 16322378

3

Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.

Dreijerink KM, Höppener JW, Timmers HM, Lips CJ. Dreijerink KM, et al. Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):562-70. doi: 10.1038/ncpendmet0292. Nat Clin Pract Endocrinol Metab. 2006. PMID: 17024155 Review.

4

Multiple endocrine neoplasia type 1: a chromatin writer's block.

Dreijerink KM, Lips CJ, Timmers HT. Dreijerink KM, et al. J Intern Med. 2009 Jul;266(1):53-9. doi: 10.1111/j.1365-2796.2009.02115.x. J Intern Med. 2009. PMID: 19522825 Free article. Review.

5

Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas.

Dreijerink KM, Varier RA, van Nuland R, Broekhuizen R, Valk GD, van der Wal JE, Lips CJ, Kummer JA, Timmers HT. Dreijerink KM, et al. Mol Cell Endocrinol. 2009 Dec 10;313(1-2):1-8. doi: 10.1016/j.mce.2009.08.020. Epub 2009 Sep 1. Mol Cell Endocrinol. 2009. PMID: 19729047 Free article.

6

Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

Pieterman CR, Vriens MR, Dreijerink KM, van der Luijt RB, Valk GD. Pieterman CR, et al. Fam Cancer. 2011 Mar;10(1):157-71. doi: 10.1007/s10689-010-9398-6. Fam Cancer. 2011. PMID: 21061174 Review.

7

Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.

van Wijk JP, Dreijerink KM, Pieterman CR, Lips CJ, Zelissen PM, Valk GD. van Wijk JP, et al. Clin Endocrinol (Oxf). 2012 Jan;76(1):67-71. doi: 10.1111/j.1365-2265.2011.04166.x. Clin Endocrinol (Oxf). 2012. PMID: 21726266

8

Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.

Pieterman CR, Conemans EB, Dreijerink KM, de Laat JM, Timmers HT, Vriens MR, Valk GD. Pieterman CR, et al. Endocr Relat Cancer. 2014 May 6;21(3):R121-42. doi: 10.1530/ERC-13-0482. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24389729 Review.

9

Breast-cancer predisposition in multiple endocrine neoplasia type 1.

Dreijerink KM, Goudet P, Burgess JR, Valk GD; International Breast Cancer in MEN1 Study Group. Dreijerink KM, et al. N Engl J Med. 2014 Aug 7;371(6):583-4. doi: 10.1056/NEJMc1406028. N Engl J Med. 2014. PMID: 25099597 Free PMC article. No abstract available.

10

Reply to: Breast cancer risk in MEN1--a cancer genetics perspective.

Dreijerink KM, Valk GD. Dreijerink KM, et al. Clin Endocrinol (Oxf). 2015 Jul;83(1):141. doi: 10.1111/cen.12679. Epub 2014 Dec 29. Clin Endocrinol (Oxf). 2015. PMID: 25409873 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page